Details of Protein
General Information of Protein (ID: PRT00611) | |||||
---|---|---|---|---|---|
Name | Myc proto-oncogene protein (MYC) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64; MYC; BHLHE39
|
||||
Gene Name | MYC | Gene ID | |||
UniProt ID | |||||
Family | Transcription factor (TF) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPP
LSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPD DETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQD LSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVL HEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRC HVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHN VLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLL RKRREQLKHKLEQLRNSCA |
||||
Structure | |||||
Function | Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Activates the transcription of growth-related genes. Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis. Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells. Functions with TAF6L to activate target gene expression through RNA polymerase II pause release. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
ADP | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | ADP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of ADP levels compared with control group. | |||||
Uridine 5'-monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Uridine 5'-monophosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of uridine 5'-monophosphate levels compared with control group. | |||||
Uridine triphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Uridine triphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of uridine triphosphate levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
Glycerol 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glycerol 3-phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glycerol 3-phosphate levels compared with control group. | |||||
Organic acids and derivatives | ||||||
2-Hydroxyglutarate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | 2-Hydroxyglutarate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of 2-hydroxyglutarate levels compared with control group. | |||||
Alanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Alanine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of alanine levels compared with control group. | |||||
Asparagine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Asparagine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of asparagine levels compared with control group. | |||||
Aspartic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Aspartic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of aspartic acid levels compared with control group. | |||||
Chloroacetic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Chloroacetic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of chloroacetic acid levels compared with control group. | |||||
cis-Aconitic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | cis-Aconitic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of cis-aconitic acid levels compared with control group. | |||||
Citric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Citric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of citric acid levels compared with control group. | |||||
Cysteine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Cysteine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of cysteine levels compared with control group. | |||||
Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glutamic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glutamic acid levels compared with control group. | |||||
Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glutamine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glutamine levels compared with control group. | |||||
Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glycine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glycine levels compared with control group. | |||||
Histidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Histidine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of histidine levels compared with control group. | |||||
Isocitrate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Isocitrate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of isocitrate levels compared with control group. | |||||
Isoleucine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Isoleucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of isoleucine levels compared with control group. | |||||
Leucine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Leucine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of leucine levels compared with control group. | |||||
Lysine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Lysine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of lysine levels compared with control group. | |||||
Malic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of malic acid levels compared with control group. | |||||
Methionine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Methionine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of methionine levels compared with control group. | |||||
Oxoglutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Oxoglutaric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
Phenylalanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Phenylalanine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of phenylalanine levels compared with control group. | |||||
Phosphoenolpyruvate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Phosphoenolpyruvate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of phosphoenolpyruvate levels compared with control group. | |||||
Proline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Proline concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the increase of proline levels compared with control group. | |||||
Pyruvic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Pyruvic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of pyruvic acid levels compared with control group. | |||||
Serine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Serine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of serine levels compared with control group. | |||||
Threonine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Threonine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of threonine levels compared with control group. | |||||
Tyrosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Tyrosine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of tyrosine levels compared with control group. | |||||
Valine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Valine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of valine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
3-Phosphoglyceric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | 3-Phosphoglyceric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of 3-phosphoglyceric acid levels compared with control group. | |||||
6-Phosphogluconic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | 6-Phosphogluconic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of 6-phosphogluconic acid levels compared with control group. | |||||
Ampicillin | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Ampicillin concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of ampicillin levels compared with control group. | |||||
Dihydroxyacetone phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Dihydroxyacetone phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of dihydroxyacetone phosphate levels compared with control group. | |||||
Fructose 1,6-bisphosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Fructose 1,6-bisphosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of fructose 1,6-bisphosphate levels compared with control group. | |||||
Glucose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glucose 6-phosphate concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glucose 6-phosphate levels compared with control group. | |||||
Glyceraldehyde 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glyceraldehyde 3-phosphate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the increase of glyceraldehyde 3-phosphate levels compared with control group. | |||||
Glycerol | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Glycerol concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of glycerol levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
Tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Tryptophan concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of tryptophan levels compared with control group. | |||||
Full List of Metabolite(s) Regulating This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Lactic acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Lactic acid addition (6 hours) | |||||
Induced Change | MYC protein expression levels: increase (FC = 1.3) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that lactic acid addition causes the increase of MYC protein expression compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Lactic acid addition (6 hours) | |||||
Induced Change | MYC mRNA levels: increase (FC = 1.3) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that lactic acid addition causes the increase of MYC mRNA levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.